dapagliflozin
astrazeneca
['dapagliflozin']
 deliver trial presentation #esccongress 20% reduction of death and hf hospitalisation in the dapagliflozin group versus placebo in hfpef patients 
MD, interventional cardiologist, PhD student, CHU Rouen